Stewart Fisher
Chief Tech/Sci/R&D Officer en C4 THERAPEUTICS, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Stewart Fisher is currently the Chief Scientific Officer at C4 Therapeutics, Inc. He previously worked as the Executive Director-Infection Bioscience at AstraZeneca PLC from 1988 to 2013.
Additionally, he held the position of Director-Quantitative, Biochemistry & Enzymology at The Broad Institute, Inc. He also served as the Head-Metabolic Diseases Department at Hoffmann-La Roche, Inc. from 1996 to 1998.
Dr. Fisher holds a doctorate degree from the California Institute of Technology and an undergraduate degree from the University of Vermont.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.19% | 07/03/2024 | 129 121 ( 0.19% ) | 1 M $ | 31/03/2024 |
Cargos activos de Stewart Fisher
| Empresas | Cargo | Inicio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2018 |
Antiguos cargos conocidos de Stewart Fisher.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/08/2013 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/08/1998 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Stewart Fisher.
| California Institute of Technology | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Stewart Fisher
